Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease

Dipyridamole treatment is associated with improved renal outcome and patient survival in advanced chronic kidney disease

Dipyridamole has been shown to decrease proteinuria and improve renal function progression especially in early chronic kidney disease (CKD) patients with glomerulonephropathy. A combination therapy of dipyridamole with aspirin could prevent second strokes in the general population. Whether these eff...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Chi-Chih Hung, Mei-Li Yang, Ming-Yen Lin, Hugo You-Hsien Lin, Lee-Moay Lim, Hung-Tien Kuo, Shang-Jyh Hwang, Jer-Chia Tsai, Hung-Chun Chen
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: Wiley 2014-12-01
Cyfres:Kaohsiung Journal of Medical Sciences
Pynciau:
Cardiovascular disease
Chronic kidney disease
Dipyridamole
End-stage renal disease
Mortality
Mynediad Ar-lein:http://www.sciencedirect.com/science/article/pii/S1607551X14002010

Rhyngrwyd

http://www.sciencedirect.com/science/article/pii/S1607551X14002010

Eitemau Tebyg